US03073E1055 - Common Stock
COR stock results show that Cencora beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
These quality stocks have real staying power and the ability to generate consistent profits and growth over the long haul.
Curious about the S&P500 stocks that are gapping on Monday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
Top S&P500 movers in Tuesday's session
Walgreens Boots Alliance Inc. narrowed its fiscal 2024 guidance even as the drugstore chain beat Wall Street’s estimates for second-quarter profit and revenue.
Hospital purchasing groups and drug distributors, some of the most powerful intermediaries in the healthcare industry, came under regulatory scrutiny. Read more here.
The pharmacy giant ended an era.
Walgreens Boots Alliance sells shares of Cencora stock for $942M while Cencora plans to repurchase shares.
Cencora (COR) declares $0.51/share quarterly dividend, in line with previous. Forward yield 0.93% Payable Feb. 26; for shareholders of record Feb. 9; ex-div Feb
Cencora reports strong Q1 2024 results, beating expectations with non-GAAP EPS of $3.28 and revenue of $72.3B (+15% YoY), with raised EPS guidance for the...
Johnson & Johnson (JNJ) agrees to pay $149.5M to settle opioid related claims in Washington State, with $123.3 million allocated to address the crisis. Read more herre.